ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INDV Indivior PLC

16.97
-0.37 (-2.13%)
May 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 48,445
Bid Price 14.35
Ask Price 27.29
News -
Day High 17.20

Low
14.3809

52 Week Range

High
26.50

Day Low 16.97
Share Name Share Symbol Market Stock Type
Indivior PLC INDV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.37 -2.13% 16.97 17:00:03
Open Price Low Price High Price Close Price Previous Close
17.18 16.97 17.20 16.97 17.34
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
936 48,445 US$ 17.10 US$ 828,618 - 14.3809 - 26.50
Last Trade Type Quantity Price Currency
15:00:07 formt 296 US$ 16.97 USD

Indivior PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.83B 135.27M - 1.09B 2M 0.01 912.16
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Indivior News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No INDV Message Board. Create One! See More Posts on INDV Message Board See More Message Board Posts

Historical INDV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week18.0218.1316.9717.6274,569-1.05-5.83%
1 Month18.6519.1316.9717.81104,865-1.68-9.01%
3 Months21.2923.2216.9720.27126,756-4.32-20.29%
6 Months16.7123.2214.380919.0997,8360.261.56%
1 Year26.5026.5014.380919.3958,099-9.53-35.96%
3 Years26.5026.5014.380919.3958,099-9.53-35.96%
5 Years26.5026.5014.380919.3958,099-9.53-35.96%

Indivior Description

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.